市場調查報告書

心臟再同步治療(CRT)市場增長,趨勢和預測(2020-2025)

Cardiac Resynchronization Therapy (CRT) Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 964901
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
心臟再同步治療(CRT)市場增長,趨勢和預測(2020-2025) Cardiac Resynchronization Therapy (CRT) Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年08月01日內容資訊: 英文 114 Pages
簡介

心臟再同步治療(CRT)市場的主要增長因素包括心力衰竭和心臟病的負擔增加,老年人口增加以及人們久坐的生活方式。

由於較低的出生率和較長的預期壽命,世界人口正在迅速老齡化。根據聯合國亞太經濟社會委員會(ESCAP)的報告,2015年亞太地區的老年人口約為6.171億,佔世界老年人口的一半以上。到2050年,估計亞太地區將佔世界老年人口的近三分之二。老年人口的增加是心血管和心力衰竭病例增加的主要原因之一。

根據2017年歐洲心臟網絡的數據,每年歐洲有390萬人死於心血管疾病(CVD),在歐盟每年有180萬人死於心血管疾病。此外,久坐的生活方式導致高血壓,高膽固醇,肥胖症高發和飲酒增加,這導致心血管疾病的高發病率。因此,久坐的生活方式有望顯著增加心血管疾病的發病率。人們對治療選擇的認識不斷提高,有望推動市場。

本報告探討了心臟再同步治療(CRT)市場,提供了市場概況,按類型,最終用戶,地區和進入市場的公司概況的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場驅動力
    • 心力衰竭和心臟損害的負擔增加
    • 老年人口的增加和久坐的生活方式的增加
  • 市場限制
    • 嚴格的規定
  • 波特的五力分析

第5章市場細分

  • 按類型
    • CRT定義器
    • CRT起搏器
  • 最終用戶
    • 醫院
    • 門診
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東/非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • Abbott Laboratories
    • BIOTRONIK
    • Boston Scientific Corporation
    • Lepu Medical Technology Co., Ltd.
    • MEDICO SpA
    • Medtronic Plc
    • Microport Scientific Corporation
    • Shree Pacetronix Ltd.

第7章 市場機會與將來動向

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 66853

The major factors for the growth of the cardiac resynchronization therapy (CRT) market include the rising burden of heart failure and cardiac disorders and an increase in the geriatric population and rising sedentary lifestyle among the population.

The global population is aging rapidly, owing to reduced birth rates and increasing life expectancy. According to a report by the United Nation Economic and Social Commission for Asia and the Pacific (ESCAP), the geriatric population in the Asia-Pacific region was around 617.1 million in 2015, accounting for more than half of the world's total elderly population. It is estimated that, by 2050, Asia-Pacific will account for almost two-thirds of the world's geriatric population. The rise in the geriatric population is one of the major reasons behind the increase in the cases of cardiovascular and heart failure.

According to the European Heart Network, 2017, every year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Furthermore, the sedentary lifestyle leads to a high prevalence of high blood pressure, high cholesterol, obesity, and high alcohol consumption, which together contributes to the high incidence of cardiovascular diseases. Therefore, the sedentary lifestyle leading to high growth in cardiovascular disease cases. The increasing awareness of the treatment options is also expected to drive the market studied

Key Market Trends

CRT - Defibrillators is the Segment by Type Expected to hold Larger Share Over the Forecast Period

The CRT - Defibrillators (CRT-D) are the special devices for heart failure patients who are also at high risk for sudden cardiac death. While functioning like a normal pacemaker to treat slow heart rhythms, a CRT-D device also delivers small electrical impulses to the left and right ventricles to help them contract at the same time. This will help your heart pump more efficiently.

A CRT-D device can also treat dangerously fast heart rhythms (arrhythmias) that can lead to sudden cardiac arrest. If the device senses heartbeats that are dangerously fast, it delivers a shock to the heart. This shock (defibrillation) stops the abnormal rhythm. Without this life-saving therapy, the dangerously rapid rhythm could lead to death in just minutes.

The use of these devices has increased recently due to the increasing incidence and mortality of cardiovascular diseases (CVD). As per a 2019 report by the American Heart Association, CVD is the leading global cause of death, accounting for more than 17.6 million deaths per year in 2016, a number that is expected to grow to more than 23.6 million by 2030. This factor is expected to increase the demand of CRT-D in future, which will boost the market growth.

North America is Expected to Hold Largest Market Share over the Forecast Period

The healthcare expenditure in the United States is among the highest, as per the GDP, globally. More than 18% of GDP is spent on healthcare each year in the United States. The country accommodates several medical device companies working on CRT therapy from around the world, having a good direct distribution channel, as well as third-party services for equipment distribution in relation to medical/hospitals requirement, and home care needs.

Furthermore, there is a rise in technological advancement in the devices. During the forecast period, the growth is expected to be consistent, with the high requirement in hospitals, for several applications across the country. Thus, owing to all the above-mentioned factors, the market is expected to witness high growth over the forecast period.

Competitive Landscape

The market studied is a consolidated market owing to the presence of few major market players. Some of the market players are Abbott Laboratories, BIOTRONIK, Boston Scientific Corporation, Lepu Medical Technology Co., Ltd., MEDICO S.p.A., Medtronic Plc, Microport Scientific Corporation, and Shree Pacetronix Ltd.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Heart Failure and Cardiac Disorders
    • 4.2.2 Increase in Geriatric Population and Rising Sedentary Lifestyle among the Population
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulations
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 CRT - Defibrillators
    • 5.1.2 CRT - Pacemakers
  • 5.2 By End User
    • 5.2.1 Hospital
    • 5.2.2 Ambulatory Care Settings
    • 5.2.3 Other
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 France
      • 5.3.2.2 Germany
      • 5.3.2.3 United Kingdom
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 BIOTRONIK
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Lepu Medical Technology Co., Ltd.
    • 6.1.5 MEDICO S.p.A.
    • 6.1.6 Medtronic Plc
    • 6.1.7 Microport Scientific Corporation
    • 6.1.8 Shree Pacetronix Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS